Biotin-FA-FMK is an inhibitor of cathepsin B and L.
CAT No: HB00032
Biotin-FA-FMK is a synthetic, biotinylated fluoromethyl ketone peptide inhibitor widely utilized in biochemical research for its potent and irreversible inhibition of cysteine proteases, particularly caspases. Structurally, it combines a reactive fluoromethyl ketone warhead with a biotin tag via a flexible fatty acid (FA) linker, enabling both targeted enzyme inhibition and subsequent affinity-based detection or purification. The dual functionality of this compound makes it a valuable tool in apoptosis research, protease activity profiling, and the development of chemoproteomic workflows. Its design allows researchers to efficiently label and capture active proteases from complex biological samples, facilitating detailed mechanistic studies and high-sensitivity analyses.
Enzyme Inhibition Assays: As a potent and irreversible inhibitor of cysteine proteases, particularly caspases, Biotin-FA-FMK is routinely used in in vitro enzyme inhibition assays. The fluoromethyl ketone moiety covalently modifies the active site cysteine residue of target proteases, thereby preventing substrate turnover and allowing for precise evaluation of enzyme activity. This property is essential for dissecting protease function in apoptosis, inflammation, and other cellular pathways where cysteine proteases play a central regulatory role. The compound's specificity and irreversible binding enable time-resolved studies and kinetic analyses, providing researchers with robust data on enzyme-inhibitor interactions.
Affinity-Based Proteomics: The biotin tag incorporated into Biotin-FA-FMK enables efficient affinity capture of protease-inhibitor complexes using streptavidin-based systems. Following incubation with biological samples, the inhibitor binds to active proteases, which can then be selectively isolated through biotin-streptavidin affinity purification. This approach allows for the enrichment and identification of active protease populations from cell lysates, tissue extracts, or other complex mixtures, supporting downstream applications such as mass spectrometry-based proteomic profiling. The strategy is particularly useful for mapping the protease landscape under physiological or experimental conditions, aiding in target validation and biomarker discovery.
Cellular Apoptosis Studies: In apoptosis research, Biotin-FA-FMK serves as a critical probe for monitoring caspase activation and function within intact cells. By irreversibly binding to active caspases, the compound enables researchers to inhibit apoptotic proteolytic cascades and assess the impact on cell fate decisions. The biotinylated structure further allows for subsequent visualization or quantification of labeled proteases using avidin-based detection methods, such as Western blotting or immunofluorescence. These capabilities support detailed investigations into the molecular mechanisms governing programmed cell death and facilitate the development of high-content screening assays for apoptosis modulators.
Chemoproteomic Target Identification: The unique combination of a reactive warhead and affinity handle in Biotin-FA-FMK makes it an ideal tool for chemoproteomic studies aimed at identifying and characterizing the targets of small-molecule inhibitors. By covalently labeling active proteases in complex proteomes, followed by affinity enrichment and analytical identification, researchers can elucidate the specificity and off-target profiles of candidate compounds. This application is particularly valuable in drug discovery and chemical biology, where understanding the interactome of bioactive molecules is critical for optimizing lead compounds and minimizing undesired effects.
Method Development and Validation: Biotin-FA-FMK finds additional utility in the development and validation of novel biochemical assays and analytical platforms. Its well-characterized inhibitory mechanism and robust biotin-based detection facilitate the benchmarking of new assay formats, including high-throughput screening systems, enzyme activity reporters, and multiplexed protease profiling technologies. By serving as a positive control or reference inhibitor, it helps ensure the reliability and reproducibility of experimental workflows, supporting both basic research and translational applications in protease biology.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.